Analysis

Earnings Preview: What to watch as Intel (INTC) prepares to report Q4 results

For Intel Corporation (NASDAQ: INTC), 2025 marked a recovery year, as the company made notable progress towards achieving its technological and operational

Key takeaways from Delta Air Lines’ (DAL) Q4 2025 earnings report

Shares of Delta Air Lines (NYSE: DAL) were down over 2% on Tuesday after the company published its fourth quarter 2025 earnings

Johnson & Johnson heads into Q4 as a more focused healthcare leader

Johnson & Johnson (NYSE: JNJ) is capitalizing on its transition from a broad-based healthcare conglomerate into a market leader in innovative medicine

Interviews

AlphaStreet's dedicated Earnings Call section is your one-source destination for all publicly listed earnings conference calls. Listen to CEOs/CFOs discuss their company's earnings reports while Wall Street Analysts ask (or grill) with their hard hitting questions.

Most Read

Key metrics from Citigroup’s (C) Q4 2025 earnings results

Citigroup Inc. (NYSE: C) reported its fourth quarter 2025 earnings results today. Revenues increased 2% year-over-year to $19.9 billion, driven by growth in Banking, Services, US Personal Banking (USPB) and

January 14, 2026

Bank of America reports higher Q4 revenue and profit; results beat estimates

Bank of America Corporation (NYSE: BAC) on Wednesday announced financial results for the fourth quarter of fiscal 2025, with strong revenue and earnings growth. The numbers also came in above

January 14, 2026

WFC Earnings: All you need to know about Wells Fargo’s Q4 2025 earnings results

Wells Fargo & Company (NYSE: WFC) reported its fourth quarter 2025 earnings results today. Total revenue increased 4% year-over-year to $21.3 billion. Net income grew 6% to $5.36 billion and

January 14, 2026

Research Summary

SentinelOne, Inc. (NYSE: S) Research Summary

SentinelOne, Inc. (NYSE: S) is a leading cybersecurity company that offers advanced threat protection

Ocean Biomedical (NASDAQ: OCEA) Research Summary

Ocean Biomedical, Inc. (NASDAQ: OCEA) is a preclinical biotech company focused on moving new

Viewing Highlight
Loading...
Highlight
Close
Top